Background/Objectives: Skin infection is common in atopic dermatitis (AD), often
| INTRODUCTION
Atopic dermatitis (AD) is a common chronic inflammatory skin condition that affects all age groups and disproportionately affects the pediatric population. This condition afflicts approximately 18% of children under age 2, 1,2 and may persist well into the second decade of life. 3 AD can disrupt normal growth and development of affected children, lead to secondary infection, significantly affect the quality of life of families with affected children, and cause financial burden. 1, 4 The role of infection in complicating AD has been well established. [5] [6] [7] Dilute bleach baths are a simple intervention that has become widely used, are safe, and are included as an adjunctive therapy in the recently published guidelines in management of AD. 8, 9 However, evidence-based guidelines for bathing have been difficult to establish. The recommendation for dilute bleach baths is based upon one randomized trial of 31 patients that showed benefit of dilute bleach baths in pediatric AD, 10 historic uses of bleach as an anti-infective, 11 and expert opinion. Given the rise of community-acquired methicillin-resistant Staphylococcus Aureus (MRSA), it is thought that frequent treatment with systemic antibiotics could lead to increased resistance in moderate-severe AD patients. However, the true mechanism of action and magnitude of effect in pediatric AD remain unclear, with suggestions that bleach may be antiinflammatory, 12 anti-biofilm, 13 or have no benefit over that of plain water baths. 14, 15 Whether or not dilute bleach baths decrease the number of systemic antibiotic courses given to children with AD is also unclear.
Dilute acetic acid (AA) is cited in the lay community, including the National Eczema Association website, as an unstudied but possible alternative therapy in AD (https://nationaleczema.org/alter native-therapies/vinegar-baths/). While promising, its role as an antiinfective in the treatment of pediatric AD has not been widely studied. Dilute AA has been used successfully on hospitalized patients at the Mayo Clinic for impetiginized AD flares since the 1980s. 16 Dilute AA is a known disinfectant and is utilized in medical settings for ulcers and burns due to its activity against S. aureus and other potentially pathogenic skin bacteria including MRSA. [17] [18] [19] As our institution has a long history of AA use, we are poised to analyze this anti-infective's associated outcomes in clinical practice. Due to parental concern of using bleach and rare reports of injury with bleach, 20 strengthening the evidence behind its use and exploring alternative effective anti-infective strategies are important for our pediatric AD population.
In this retrospective study, we aimed to assess whether various recommendations for anti-infective bathing additives were associated with differences in the number of systemic antibiotic courses for skin infections over 1 year. We also examined our institutional trends in practice regarding anti-infective use in AD both before and after the widespread introduction of dilute bleach baths. 
| METHODS

| Study population and data collection
| Assessment of effectiveness
Systemic antibiotic courses for treatment of skin infection over the 1-year period following the identification of superinfection were tallied as the primary outcome. Electronic medical records were reviewed for outpatient oral antibiotic prescriptions and inpatient oral or intravenous antibiotic administrations.
| Statistics
Patient and disease characteristics of the patients diagnosed with AD by dermatology were compared between the two time cohorts Continuous variables were summarized as means or medians and compared using Kruskal-Wallis test. All analyses were performed using SAS version 9.3 (SAS Institute, Cary NC, USA). A P value of < 0.05 was considered statistically significant, and all statistical tests were two-sided. thus, the two groups were deemed to be of comparable AD severity.
| RESULTS
| Patient characteristics
A total of 351 (46%) were defined as infected; this proportion was similar between the temporal cohorts (50.8% vs 43.8%, respectively, P = 0.057, 
| Anti-infective recommendations
Patients with any specific bathing or wet wrap recommendations increased from 29% to 63% between the two time periods, and the number of patients given topical anti-infective recommendations increased from 12% to 51% (Table 1 
| Systemic antibiotics
Of Table 2 ); however, there was a small decrease in the average number of courses of systemic antibiotic courses in 1 year between the temporal cohorts (1.9 per year vs 1.5 per year, P = 0.010, Table 2 ). As noted above, this decrease could not be attributed to the use of anti-infectives (Table 4) .
| DISCUSSION
Topical therapy for pediatric AD is typically centered on the use of topical corticosteroids to lower inflammation and pruritus. Skin damage caused by inflammation and scratching creates portals of entry for bacteria, especially S. aureus, resulting in superinfection, 5, 7, 11 which can lead to frequent use of systemic antibiotics. Early rationale for studying topical anti-infectives included the concern that continued use of systemic antibiotics would lead to resistance of While current recommendations suggest that dilute bleach baths may be clinically helpful in patients with moderate-to-severe AD, the evidence is limited, and other anti-infectives have not been widely studied. 8, 9 Since publication of the AD guidelines, small clinical trials have been published that support the use of dilute bleach as an adjunct in treatment of adult and pediatric AD; 22 however, two recent small clinical trials questioned the effectiveness of dilute bleach additives vs plain water baths. 14, 15 There is data to support the role of bleach as an anti-inflammatory via the NF-kB pathway in the skin in cultured keratinocytes, in in vivo mouse models for radiation dermatitis and aging, 12 and in decreasing S. aureus biofilms. 13 as an increase in topical anti-infectives prescribed. This is consistent with the evolving understanding and practice. These findings were equally true for patients in whom no specific bathing recommendations and tap water only were made; thus, we cannot attribute this change to increasing recommendations for topical anti-infectives.
T A B L E 2 Systemic antibiotics, topical antibiotics and antiinfectives in infected patients
While we also report culture data where available, given that culture could have occurred before or after exposure to additive, it is less clear what direct effect each additive had on each type of bacteria.
One hypothesis is that topical anti-infectives may serve as an anti-inflammatory treatment, rather than as an antimicrobial, yet this remains to be determined. 12, 15 It is possible that an effective anti- dressings, 16 or bathing additives to help to control or treat pediatric AD; 9,10 however, the evidence is limited, and the true mechanism of action of some of these interventions is not known.
Our study has several limitations. Due to its retrospective nature, we were unable to confirm patient compliance with bathing recommendations. Also, the effect of dilute baths was shown in Huang's study when concomitantly used with intranasal mupirocin. 10 In our population, while some patients were prescribed mupirocin, it was often used primarily on skin and often prescribed by primary care before or during dermatology treatment course. We were unable to control for severity of disease not requiring immunosuppression, phototherapy, or strong topical steroids. For example, AA is often used in the treatment protocols of the hospitalized wet dressing patients; thus, it may be that this subset was more severely affected, thus biasing our results. Further, we were unable to assess other aspects of patient adherence, such as total number of days a particular strength steroid was used, or body surface area to which it was applied.
Overall, neither dilute AA, tap water wet wraps, nor dilute bleach baths were associated with decreased exposure to systemic antibiotics in superinfected pediatric AD patients. While dilute bleach baths have greatly increased in use over the last decade and are a low-risk adjunctive treatment, the evidence for dilute bleach over other potential additives, or even no additives, remains limited. We do not recommend changing current clinical practice recommendations given the potential benefit and minimal harm of topical antiinfectives; however, we suggest that a no additive control group and AA additives be used in the future prospective studies on anti-infectives to further discern any potential benefits of these therapies.
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